Durham.

PositionTriangle

DURHAM--Argos Therapeutics raised $25 million in venture-capital financing that will enable it to complete another round of clinical trials of a kidney-cancer treatment. The lead investor is private-equity group Forbion Capital...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT